Panel discussion with Healthcare experts about synthetic data
Agenda
In the middle of the data revolution, the urge to innovate with data is especially relevant in Healthcare and Life Science. The complexity and constantly changing regulatory requirements have a significant impact on the use of sensitive data among organizations in this sector. Moreover, data is crucial for making better decisions and ensuring effective treatments. With the use of a synthetic data approach, healthcare organizations can accelerate their data initiatives, improve patient care, and transform the way healthcare is delivered. This allows researchers, doctors, and data experts to innovate and analyze without risking patient privacy, especially as data breaches in healthcare are on the rise.
Panelists:
1) Wim Kees Janssen, CEO, an AI-generated test data expert - Syntho
As founder and CEO of Syntho, Wim Kees aims to turn privacy by design into a competitive advantage with AI-generated test data. Hereby, he aims to solve key challenges that are introduced by classic test Data Management tools, which are slow, require manual work, and do not offer production-like data and consequently introduce "legacy-by-design".
2) Edwin van Unen, Principal Analytics Consultant - SAS
Principal Analytics Consultant helping companies using Business Analytics and Data Science to innovate and optimize business processes by adding value with Predictive Analytics and Operations Research.
3) Frederick Droppert, Lawyer IP, IT & Privacy - BG.legal
Frederick is an IT / Privacy legal professional with a passion for everything related to tech. Always looking at emerging technologies, both from a legal as well as a technological perspective
4) Uliana Krainska, Business Development Executive - Syntho
Uliana is helping enterprise clients unlock privacy-sensitive data, make smarter data decisions and faster data access, so that organizations can realize data-driven innovation.